scholarly journals Multidimensional Comparison of Cancer-Related Fatigue and Chronic Fatigue Syndrome: The Role of Psychophysiological Markers

2019 ◽  
Vol 16 (1) ◽  
pp. 71-79 ◽  
Author(s):  
Hye Youn Park ◽  
Hong Jun Jeon ◽  
Young Rong Bang ◽  
In-Young Yoon
Biomolecules ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 185
Author(s):  
Maria Eugenia Ariza

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) or Systemic Exertion Intolerance Disease (SEID) is a chronic multisystem illness of unconfirmed etiology. There are currently no biomarkers and/or signatures available to assist in the diagnosis of the syndrome and while numerous mechanisms have been hypothesized to explain the pathology of ME/CFS, the triggers and/or drivers remain unknown. Initial studies suggested a potential role of the human herpesviruses especially Epstein-Barr virus (EBV) in the disease process but inconsistent and conflicting data led to the erroneous suggestion that these viruses had no role in the syndrome. New studies using more advanced approaches have now demonstrated that specific proteins encoded by EBV could contribute to the immune and neurological abnormalities exhibited by a subgroup of patients with ME/CFS. Elucidating the role of these herpesvirus proteins in ME/CFS may lead to the identification of specific biomarkers and the development of novel therapeutics.


Author(s):  
Stefan Kempke ◽  
Boudewijn Van Houdenhove ◽  
Stephan Claes ◽  
Patrick Luyten

2018 ◽  
pp. 24-31
Author(s):  
V. V. Tsaryk ◽  
A. K. Novoskoltsev

At the issue represented the etiopathogenesis of the chronic fatigue syndrome of (CFS) with immune dysfunction. Many doctors consider this problem only from the point of view of non-psychological disorders requiring only psycho-correction and non-drug treatment. However, syndromocomplex of CFS includes not only neuropsychiatric disorders, but also fibromyalgia syndrome, unexplained genesis, lymphadenopathy, non-specific polyarthralgias. It is also controversial about the feasibility of treating type 6 herpesviruses and type 7 viruses. Some authors consider the need for antiviral therapy only when reactivating the herpesvirus infection, in the transplantation of organs and tissues. However, for frequent HHV-7 and HHV-6 viremia remains resistant to ganciclovir, unlike CMV and EBV, which is successfully controlled by viremia.


2021 ◽  
Vol 10 (20) ◽  
pp. 4786
Author(s):  
Undine-Sophie Deumer ◽  
Angelica Varesi ◽  
Valentina Floris ◽  
Gabriele Savioli ◽  
Elisa Mantovani ◽  
...  

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic systemic disease that manifests via various symptoms such as chronic fatigue, post-exertional malaise, and cognitive impairment described as “brain fog”. These symptoms often prevent patients from keeping up their pre-disease onset lifestyle, as extended periods of physical or mental activity become almost impossible. However, the disease presents heterogeneously with varying severity across patients. Therefore, consensus criteria have been designed to provide a diagnosis based on symptoms. To date, no biomarker-based tests or diagnoses are available, since the molecular changes observed also largely differ from patient to patient. In this review, we discuss the infectious, genetic, and hormonal components that may be involved in CFS pathogenesis, we scrutinize the role of gut microbiota in disease progression, we highlight the potential of non-coding RNA (ncRNA) for the development of diagnostic tools and briefly mention the possibility of SARS-CoV-2 infection causing CFS.


BMJ ◽  
1994 ◽  
Vol 308 (6939) ◽  
pp. 1297-1301 ◽  
Author(s):  
C Blatch ◽  
T Blatt ◽  
A Wilson ◽  
I Hickie ◽  
A Lloyd ◽  
...  

Pain Medicine ◽  
2008 ◽  
Vol 9 (8) ◽  
pp. 1164-1172 ◽  
Author(s):  
Jo Nijs ◽  
Karen Van de Putte ◽  
Fred Louckx ◽  
Steven Truijen ◽  
Kenny De Meirleir

2003 ◽  
Vol 33 (7) ◽  
pp. 1185-1192 ◽  
Author(s):  
SIMON HATCHER ◽  
ALLAN HOUSE

Background. The role of stress in the onset of chronic fatigue syndrome is unclear. Our objectives in this study were first, to determine the relation between the onset of chronic fatigue syndrome and stressful life events and difficulties. Secondly, we examined the role of a particular type of problem, dilemmas, in the onset of chronic fatigue syndrome.Method. We used a case–control design with 64 consecutive referrals from an Infectious Diseases/Liaison Psychiatry Fatigue clinic and 64 age- and sex-matched controls from a general practice population control group in Leeds. We had two main outcome measures; the odds ratios of the risk of developing chronic fatigue syndrome after experiencing a severe life event, severe difficulties or both in the year and 3 months preceding onset; and the proportion of subjects in each group who experienced a dilemma prior to onset.Results. Patients with chronic fatigue syndrome were more likely to experience severe events and difficulties in the 3 months (OR=9, 95% CI 3·2 to 25·1) and year (OR=4·3, 95% CI 1·8 to 10·2) prior to onset of their illness than population controls. In the 3 months prior to onset 19 of the 64 patients (30%) experienced a dilemma compared to none of the controls.Conclusions. Chronic fatigue syndrome is associated with stressful events and difficulties prior to onset. Those events and difficulties characterized as being dilemmas seem to be particularly important.


Sign in / Sign up

Export Citation Format

Share Document